- Zacks via Yahoo FinanceMay 17 12:35 PM
J&J JNJ detailed a new five-year growth plan for its Pharmaceutical segment, its largest unit, at its analyst day.
- Market Watch3 days ago
Hartford Jury Returns $542K Verdict Against Boehringer Ingelheim in Pradaxa Blood Thinner Case | Connecticut Law TribuneLaw.com2 days ago
Opioids Market scenario 2019 | Global Industry Analysis By Size, Share, Regional Trends, Growth Factors, Historical Analysis, Business...Market Watch1 day ago
- Thomson Reuters StreetEvents via Yahoo FinanceMay 06 6:57 AM
While still relatively early in their product life cycles, these products continue to drive growth led by Trulicity, Taltz, Verzenio and in collaboration with Boehringer Ingelheim ...
- Fortune via Yahoo FinanceMay 21 13:41 PM
DEBUT DEAL Mary Meeker has made her first investment out of Bond Capital, the new firm she launched after spinning out of Kleiner Perkins last year. Bond, which has raised $1.25 billion, participated ...